Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2013

Sep 27, 2013

35119_dirs_2013-09-27_393aebab-8330-4e19-8f19-0a37a0e6c384.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2013-09-25

Reporting Person: BREY ROBERT N (Chief Scientific Offr & Sr. VP)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-09-25 Stock Option (Right to Buy) $0.68 A 35000 Acquired 2022-12-04 Common Stock (35000) Direct

Footnotes

F1: The Issuer granted the stock option on December 5, 2012 (the "Grant Date"), subject to stockholder approval of an amendment to increase in the number of shares available for issuance the Company's 2005 Equity Incentive Plan (the "2005 Plan") under which the stock option was granted. The Issuer's stockholders approved the amendment to the 2005 Plan on September 25, 2013. The stock option vests immediately as to 8,750 shares and vests as at a rate of 2,188 shares on each three (3) month anniversary of the Grant Date.